[ad_1]
Developing the Corona virus vaccine, Prof. Dr. It is stated that, following the positive data from BioNTech, founded by Uğur Şahin, and the American pharmaceutical company Pfizer, they will send the approval request for the corona virus vaccine to the United States this month.
Pfizer signed a $ 1.95 billion agreement with the United States government in July. This vaccine, which was administered in two doses, was reported to cost TL 159 per dose and TL 318 for two doses in the United States.
GERMANY EXPECTS VACCINES IN THE FIRST QUARTER OF 2021
In the statement made by the German Ministry of Health, it was indicated that the vaccine will not be taken before the first quarter of 2021.
“Assuming a positive risk-reward ratio can be confirmed, the first approvals are expected to arrive in the first quarter of 2021 at the earliest,” the statement said.
“THE VACCINE IS 90 PERCENT EFFECTIVE”
In developing a vaccine with Germany-based BioNTech against COVID-19, Pfizer announced that the vaccine was more than 90 percent effective in results.
The Turkish CEO of BioNTech, which developed the vaccine, said: “This is a victory. “The vaccine will protect people from the disease for at least 1 year.” Sozcu.com.tr-DHA
It may interest you
It may interest you
[ad_2]
